Top Markets
#1 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +593.28%
#2 Phala Phala +59.93%
#3 Bitway Bitway +34.54%
#4 Backpack Backpack +33.40%
#5 龙虾 (Lobster) 龙虾 (Lobster) +25.98%
#6 ARK ARK +24.60%
#7 Mubarak Mubarak +23.76%
#8 The Black Bull The Black Bull +22.66%
#9 Aerodrome Finance Aerodrome Finance +20.05%
#10 PulseChain PulseChain +19.86%
Coin of the day
Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Rang in Aktien #492
Operating globally, Becton, Dickinson and Company (BD) is a prominent... Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.
Aktienkurs
$183.43
Marktkapitalisierung
$50.54B
Veränderung (1 Tag)
2.13%
Veränderung (1 Jahr)
29.20%
Land
US
Handel Becton, Dickinson and Company (BDX)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von Becton, Dickinson and Company (BDX)
Anzahl der ausstehenden Aktien zum June 2026: 274.79M
Laut den neuesten Finanzberichten und dem Aktienkurs von Becton, Dickinson and Company beträgt die aktuelle Anzahl der ausstehenden Aktien 274.79M. Am Ende von September 2024 hatte das Unternehmen 289.76M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Becton, Dickinson and Company (BDX) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 274.79M -4.13%
2025 286.61M -1.09%
2024 289.76M 1.22%
2023 286.28M 0.45%
2022 285.01M -1.48%
2021 289.29M 3.70%
2020 278.97M 3.34%
2019 269.94M 4.49%
2018 258.35M 18.00%
2017 218.94M 2.93%
2016 212.70M 5.02%
2015 202.54M 4.78%
2014 193.30M -0.95%
2013 195.16M -5.01%
2012 205.46M -7.11%
2011 221.18M -5.61%
2010 234.33M -2.56%
2009 240.48M -1.57%
2008 244.32M -0.35%
2007 245.19M -0.92%
2006 247.46M -1.62%
2005 251.53M 0.01%
2004 251.51M -1.19%
2003 254.54M -1.37%
2002 258.07M 0.27%
2001 257.37M 1.64%
2000 253.23M 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 354.50M 29.01%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 461.20M 67.84%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH
Medline Inc. Medline Inc.
Medline Inc.
MDLN.US
 - -
US